Trial Profile
A Randomized, Placebo-controlled, Double-blind, Multiple-ascending-dose Study to Assess the Safety and Tolerability of XAF5 Gel Applied to the Skin of Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Feb 2016
Price :
$35
*
At a glance
- Drugs XAF 5 (Primary)
- Indications Subcutaneous fat disorders
- Focus Adverse reactions
- Sponsors Topokine Therapeutics
- 12 May 2014 New trial record